AMGEN INC — Director's Dealing 2022

Jan 7, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vigil Neuroscience, Inc. (VIGL)
CIK: 0001827087
Period of Report: 2022-01-06

Reporting Person: AMGEN INC (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Preferred Stock	$		Common Stock (3206281)		Direct

Footnotes

F1: These shares of Series A Preferred Stock are convertible into shares of the Issuer's common stock on a one-for-2.7732 basis and, upon completion of the Issuer's initial public offering, will automatically convert into the number of shares of the Issuer's common stock shown in Column 3.

F2: 10% beneficial ownership is calculated in accordance with SEC rules based on the number of shares of the Issuer's common stock outstanding on the date hereof and the conversion of only the reporting person's shares of preferred stock.